(Q40494910)

21 September 2017

1 reference

title

Dormancy of Mycobacterium tuberculosis and latency of disease (English)

1 reference

Mycobacterium tuberculosis

21 September 2017

0 references

author name string

L G Wayne

series ordinal

1

1 reference

21 September 2017

1 November 1994

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

21 September 2017

1 reference

21 September 2017

13

1 reference

21 September 2017

908-914

1 reference

21 September 2017

11

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02111491

21 September 2017

0 references

cites work

Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis. A risk to patients and health care workers

1 reference

https://api.crossref.org/works/10.1007%2FBF02111491

Does the risk of tuberculosis increase in old age?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02111491

A mouse model of the recrudescence of latent tuberculosis in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02111491

Experimental Study on the Relapse of Tuberculosis after the Termination of Antituberculous Chemotherapy Using Immunodeficient Nude Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02111491

The effects of exposure time, drug concentration, and temperature on the activity of ethambutol versus Mycobacterium tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02111491

Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02111491

Enzyme systems in the mycobacteria. XIII. Glycine dehydrogenase and the glyoxylic acid cycle

21 January 2018

1 reference

12 December 2020

Dynamics of submerged growth of Mycobacterium tuberculosis under aerobic and microaerophilic conditions

1 reference

12 December 2020

Autolysis and secondary growth of Mycobacterium tuberculosis in submerged culture.

1 reference

12 December 2020

Enumeration of viable tubercle bacilli from the organs of nonimmunized and immunized mice

1 reference

12 December 2020

[Sterilizing activity of the main drugs on the mouse experimental tuberculosis (author's transl)]

1 reference

12 December 2020

Control of tuberculosis in the United States. American Thoracic Society

1 reference

12 December 2020

The clinicopathologic significance of the demonstration of viable tubercle bacilli in resected lesions

1 reference

12 December 2020

Synchronized replication of Mycobacterium tuberculosis

1 reference

12 December 2020

Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. I. The persistence of drug-susceptible tubercle bacilli in the tissues despite prolonged antimicrobial therapy

1 reference

12 December 2020

An experimental model of chemotherapy on dormant tuberculous infection, with particular reference to rifampicin

1 reference

12 December 2020

Experimental models to explain the high sterilizing activity of rifampin in the chemotherapy of tuberculosis

1 reference

12 December 2020

Ineffectiveness of isoniazid in modifying the phenomenon of microbial persistence

1 reference

12 December 2020

Glyoxylate metabolism and adaptation of Mycobacterium tuberculosis to survival under anaerobic conditions

1 reference

12 December 2020

The bacteriology of respected tuberculous pulmonary lesions. 2. Observations on bacilli which are stainable but which cannot be cultured

1 reference

12 December 2020

The sterilizing value of rifampicin and pyrazinamide in experimental short-course chemotherapy

1 reference

12 December 2020

Antigenic differences between extracts of actively replicating and synchronized resting cells of Mycobacterium tuberculosis

1 reference

12 December 2020

The fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. II. The conversion of tuberculous infection to the latent state by the administration of pyrazinamide and a companion drug

1 reference

12 December 2020

Mycobacterial virulence. Virulent strains of Mycobacteria tuberculosis have faster in vivo doubling times and are better equipped to resist growth-inhibiting functions of macrophages in the presence and absence of specific immunity

1 reference

12 December 2020

The early bactericidal activity of drugs in patients with pulmonary tuberculosis

1 reference

12 December 2020

The competing risks of tuberculosis and hepatitis for adult tuberculin reactors

1 reference

12 December 2020

The in vitro action of antituberculous agents against multiplying and non-multiplying microbial cells

1 reference

12 December 2020

Pyrazinamide sterilizing activity in vitro against semidormant Mycobacterium tuberculosis bacterial populations

1 reference

12 December 2020

The effect of pulsed exposures to rifampin on the uptake of uridine- 14 C by Mycobacterium tuberculosis

1 reference

12 December 2020

REPORT of panel discussion on survival and revival of tubercle bacilli in healed tuberculous lesions

1 reference

12 December 2020

An explanation for the arithmetic linear growth of mycobacteria.

1 reference

12 December 2020

Tuberculosis in elderly persons

1 reference

12 December 2020

Activity of rifampicin administered daily and intermittently on experimental tuberculosis in mice

1 reference

12 December 2020

Studies on the growth of Mycobacteria. I. The occurrence of arithmetic linear growth

1 reference

12 December 2020

The new tuberculosis.

1 reference

12 December 2020

The bacteriology of resected tuberculous pulmonary lesions. I. The effect of interval between reversal of infectiousness and subsequent surgery

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02111491

1 reference

PubMed ID

7698116

Dimensions Publication ID

21 September 2017

0 references

1 reference

PubMed ID

7698116